Oral Anticoagulation vs. Watchman in Non-Valvular Atrial Fibrillation

To learn more about Cleveland Clinic’s Atrial Fibrillation Stroke Prevention Center, please visit http://cle.clinic/2KzOgFe

Patients often ask why they need to be on an anticoagulant after ablation – or – if they can have a Watchman device at the same time as an ablation. Dr. Saliba and Dr. Wazni discuss the answers to these questions. The OPTION trial is looking at the safety and effectiveness of the Watchman device (left atrial appendage closure) vs. oral anticoagulant medications in patients with non-valvular atrial fibrillation.

Patients who have had an ablation or who are going to have an ablation will be randomized to WATCHMAN device vs. oral anticoagulation. Patients are followed for three years, looking at outcomes of stroke, mortality, cardiovascular events and risk of bleeding. Interested patients should talk with their doctor or contact the Atrial Fibrillation Stroke Prevention Center.

To learn more about the OPTION trial, please visit https://clinicaltrials.gov/ct2/show/N...

▶Share this video with others:    • Oral Anticoagulation vs. Watchman in ...  

▶Subscribe to learn more about Cleveland Clinic: https://www.youtube.com/user/Clevelan...